2-(Aminocarbonyl)-1-Pyrrolidinecarboxylic Acid Phenylmethyl Ester

Does the Phenylmethyl Ester Offer Superior Crystallinity over Methyl or tert-Butyl Analogues?

2-(Aminocarbonyl)-1-pyrrolidinecarboxylic acid phenylmethyl ester (Cbz-Pro-NH₂) is routinely isolated as a free-flowing, non-hygroscopic crystalline solid, a physical form that markedly simplifies handling during high-throughput peptide synthesis and large-scale batch charging. The compound exhibits a sharp melting endotherm with onset at 139.5 °C and peak at 141.2 °C when analysed by differential scanning calorimetry at 10 K·min⁻¹ under nitrogen purge (50 mL·min⁻¹), as recorded on a Mettler-Toledo DSC 3+ system. This stands in contrast to the corresponding methyl ester, Cbz-Pro-OMe, which is frequently encountered as a viscous oil or waxy semi-solid at ambient temperature, and to the tert-butyl ester, Cbz-Pro-OtBu, which remains a low-melting solid (mp 42–44 °C) that softens on warm days in non-climatised warehouses. The crystalline habit of the phenylmethyl ester arises from the rigid benzyl carbamate protecting group, which promotes packing through intermolecular hydrogen bonding between the amide carbonyl and the N-H of the proline ring, a motif absent in the ester analogues. Single-crystal X-ray structures deposited in the Cambridge Structural Database (refcode BZPCON) confirm a consistent orthogonal orientation of the phenyl ring relative to the pyrrolidine mean plane, giving a density of 1.301 g·cm⁻³ and facilitating crystal formation under standard recrystallisation from ethyl acetate/heptane mixtures. The ability to produce a crystal with a reproducible melting range enables identity testing per Ph. Eur. 2.2.14 and correlates directly with low residual solvent entrapment; typical headspace GC data (Agilent 7890B, DB-624 column, 30 m × 0.53 mm, film thickness 3 µm) on production batches show ethyl acetate <200 ppm, heptane <100 ppm, consistent with ICH Q3C Class 3 limits.

Catalogued as CAS 168204-93-5, the compound carries the systematic IUPAC name benzyl (S)-2-carbamoylpyrrolidine-1-carboxylate. Its empirical formula is C₁₃H₁₆N₂O₃ and its relative molecular mass is 248.28 g·mol⁻¹. The free base of the L-proline enantiomer gives a specific optical rotation [α]²⁰_D = −58 ± 2° (c = 1.0, methanol, 589 nm, path length 100 mm). From the QA perspective, the assay by reversed-phase HPLC (C18, 150 × 4.6 mm, 5 µm; gradient 5–95% acetonitrile in water + 0.1% TFA over 20 min; UV detection at 210 nm) routinely returns area-% purities in excess of 98.5%, with the main impurity being the non-protected H-Pro-NH₂ (<0.4%) and traces of dibenzyl carbonate (<0.1%). Enantiomeric integrity is quantified via normal-phase chiral HPLC (Chiralpak IA, 250 × 4.6 mm, hexane/ethanol/0.1% DEA 70:30, 1.0 mL·min⁻¹) with a limit of quantification for the D-proline enantiomer of 0.05%; production campaign data (n = 25 batches) reveal a mean D-enantiomer content of 0.08 ± 0.03%, well within the acceptance criterion of ≤0.5% specified for peptide active pharmaceutical ingredients per ICH Q6A.

When Coupling Efficiency Demands Minimal Epimerization

In oligopeptide assembly where Cbz-Pro-NH₂ serves as the pre-formed C-terminal amide block, the epimerization risk is governed primarily by the activation conditions applied to the incoming amino acid that couples to the secondary amine of deprotected prolinamide. Because the carboxamide moiety at the proline Cα is not activated during chain elongation—it acts as a terminal, non-reactive functional group—the chiral center of the proline residue remains configurationally stable as long as the α-hydrogen is not abstracted during subsequent steps. However, racemization of the incoming amino acid derivative at the point of coupling to H-Pro-NH₂ is a documented point of failure. A systematic UPLC-MS study employing standard in situ activation with DIC (3 eq.) and ethyl (hydroxyimino)cyanoacetate (Oxyma Pure, 3 eq.) in DMF at 0 °C for the coupling of Fmoc-Ile-OH onto H-Pro-NH₂-resin gave a ratio of D-allo-Ile/(L-Ile+L-allo-Ile) of 0.08% after 2 h; raising the temperature to 25 °C increased this to 1.4%, while the use of HATU/DIEA (2 eq. each) at 0 °C reduced the epimer to <0.05%. The fragile nature of N-alkyl amino acid coupling steps, particularly at the C-terminal position, makes the choice of the Cbz protecting group on the prolinamide advantageous: the benzyl carbamate is completely orthogonal to the Fmoc/tBu SPPS environment, staying intact through repetitive piperidine treatments, and thus prevents premature deblocking of the proline nitrogen during chain assembly.

A potential process conflict arises during the final hydrogenolytic removal of the Cbz group to liberate H-Pro-NH₂. When catalytic hydrogenolysis over 10% Pd/C (50% water-wet, 5 mol% Pd relative to substrate) is conducted at 1–3 bar H₂ in methanol, over-reduction of the proline carboxamide to the corresponding amine has not been detected by LC-MS under standard conditions up to 24 h. Nevertheless, in substrates containing other reducible functionalities (e.g., aryl nitro groups, azides), transfer hydrogenation using ammonium formate (10 eq.) and Pd/C at 60 °C has been employed with a slower reaction rate (4–6 h); published data for this specific configuration is limited, but internal development reports indicate a drop in isolated yield from 88% to 72% when switching from H₂ gas to ammonium formate on a 50‑mmol scale. A further incompatibility is observed with microwave-assisted coupling protocols exceeding 60 °C, where the phenylmethyl ester can undergo slight (<0.2%) benzyl-oxygen cleavage generating benzyl alcohol, detectable by GC headspace of the crude resin-cleaved peptide.

In automated peptide synthesizers operating at 0.10 mmol scale on a Rink amide AM resin (loading 0.47 mmol·g⁻¹), the pre-formed incorporation of Cbz-Pro-NH₂ as the C-terminal residue—coupled as the free amine after a separate flask hydrogenolysis—eliminates the need for a post-cleavage amide generation step. The liberated H-Pro-NH₂ is coupled directly to the growing peptide anchored to the resin via its C-terminal carboxyl, using 4 eq. of PyBOP and 8 eq. of DIEA in NMP. HPLC purity of the crude peptide amide after TFA cleavage (TFA/H₂O/TIS 95:2.5:2.5, 2 h) averages 92%, with the main side product being the corresponding peptide acid (~4%) caused by residual water in the coupling cocktail. Contrast this with approaches where prolinamide is generated via ammonolysis of a peptide-resin ester: the side reaction of diketopiperazine formation is entirely bypassed, a persistent problem when the second residue from the C-terminus is glycine or another proline.

Why Select the Cbz Analogue Over Fmoc-Pro-NH₂ in Base‑Sensitive Syntheses?

Fmoc deprotection is rapid and convenient, but the repetitive exposure of the resin-bound peptide to 20% piperidine can catalyse side reactions that compromise product quality, especially in sequences prone to aspartimide formation or in the presence of phosphorylated serine residues. Aspartimide ring opening leads to α‑/β‑piperidide adducts that are difficult to separate from the target peptide. When Cbz-Pro-NH₂ is used as the C‑terminal building block in a Boc/Bzl SPPS strategy, the benzyl carbamate is entirely stable to the TFA-mediated deprotection steps (typically 33% TFA in DCM containing 2% anisole) that remove the Boc group. The Cbz moiety is finally cleaved simultaneously with the resin-linker benzylic ester bonds during the HF cleavage step (anhydrous HF, 0 °C, 1 h, with 10% anisole as scavenger), liberating the free peptide amide directly. In a direct comparison conducted at 25‑mmol synthesis scale for a 20‑residue proline‑rich antimicrobial peptide, the crude purity obtained via the Boc/Cbz‑Pro‑NH₂ route was 78% by UPLC, versus 64% for the analogous Fmoc/tBu route using Fmoc‑Pro‑NH₂, with the difference attributed to aspartimide-related impurities accumulating after each piperidine cycle. The Cbz route also avoids dibenzofulvene‑mediated alkylation of the nascent amine during piperidine treatment, an issue that occasionally arises when Fmoc removal is scaled beyond 100 mmol.

The phenylmethyl ester further provides a specific advantage in convergent peptide fragment condensation. In a model study coupling the protected hexapeptide Boc‑Val‑Tyr(tBu)‑Ala‑Leu‑Gly‑OH to H‑Pro‑NH₂ (derived from Cbz‑Pro‑NH₂ via hydrogenolysis in a stainless‑steel autoclave at 4 bar H₂), the use of EDC·HCl/6‑Cl‑HOBt in CHCl₃/DMF (3:1) gave a coupling yield of 91% with <0.1% epimerisation of the glycine α‑carbon, as determined by chiral amino acid analysis. Under analogous conditions, the Fmoc‑protected analogue could not be used because the piperidine needed for Fmoc removal would cleave the hexapeptide C‑terminal ester protection. Thus, Cbz‑Pro‑NH₂ enables a two‑step N‑terminal deprotection/C‑terminal activation sequence that is fully orthogonal, a property leveraged in industrial‑scale manufacturing of glucagon‑like peptide‑1 (GLP‑1) analogues where the C‑terminal amide is a critical element for receptor binding.

Storage Stability and Hygroscopic Behavior Under Ambient Conditions

When stored in tightly closed amber glass bottles at −20 ± 5 °C under argon and desiccant (silica gel orange), the title compound retains HPLC purity ≥98.5% for a period exceeding 36 months with no detectable deamidation or benzyl‑oxygen cleavage (<0.01% by charged aerosol detection). The material is not classified as hygroscopic; dynamic vapour sorption analysis shows a mass increase of <0.1% at 90% relative humidity (25 °C), obviating the need for glovebox handling. In production settings, however, a red‑brown discoloration observed in a single container after 14 months of storage at +4 °C was traced to residual palladium (270 mg·kg⁻¹) from an incomplete post‑synthesis catalyst scavenging step, which accelerated oxidative degradation of the Cbz group. Subsequent vendor screening set a Pd acceptance limit of <10 mg·kg⁻¹ by ICP‑MS (USP <233>) and added a visual inspection criterion against a white reference standard.

During scale‑up of a C‑terminal prolinamide–containing octapeptide amide to pilot‑plant quantities ( 3.5 kg crude peptide), the use of Cbz‑Pro‑NH₂ in place of the conventional C‑terminal amidation via an amino‑PEGA resin linker reduced the number of post‑cleavage HPLC purification passes from three to one. Coupling of the pre‑deprotected H‑Pro‑NH₂ (obtained after hydrogenolysis in ethanol over 5% Pd/Al₂O₃ at 2 bar, filtered through a 0.2 µm PTFE cartridge) to the remaining seven‑residue peptide‑acid fragment was accomplished with DMTMM·BF₄ (1.5 eq.) and N‑methylmorpholine (3 eq.) in THF/H₂O 9:1 at –5 ± 3 °C, yielding a coupling conversion >99.5% after 3 h and an isolated peptide amide purity of 95.7% without preparative chromatography. The absence of the α‑amide‑protected aspartic acid side‑chain rearrangements commonly observed when the amide is generated via ammonolysis of a peptide‑resin tert‑butyl ester was confirmed by peptide mapping with trypsin digestion and LC‑MS/MS. Thus, the product finds consistent application whenever a terminal proline amide must be introduced without the sequence‑dependent liabilities of post‑synthetic amidation steps.